Viracta Therapeutics Inc
NASDAQ:VIRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Viracta Therapeutics Inc
NASDAQ:VIRX
|
US |
Intrinsic Value
The intrinsic value for Viracta Therapeutics Inc (VIRX) under the Base Case is 0.0144 USD. Compared with the current market price of 0.0098 USD, the stock appears Undervalued by 32%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Viracta Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Viracta Therapeutics Inc
Earnings Waterfall
Viracta Therapeutics Inc
The intrinsic value for Viracta Therapeutics Inc (VIRX) under the Base Case is 0.0144 USD.
Compared with the current market price of 0.0098 USD, the stock appears Undervalued by 32%.